Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer
Abstract
We report on 14 patients treated with linac- or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrence from prostate cancer, up to the mean dose of 30
Gy/3 fractions. At the mean follow-up of 18.6
months, five patients experienced clinical out-field progression. Toxicity was minimal. Further investigation is warranted in order to identify the patients that benefit most from this treatment modality and to define the optimal association of such local approach with androgen deprivation. Hopefully, effective local therapy might reduce the burden of systemic therapies given to the recurrent/metastatic prostate cancer patients.
Keywords: Recurrent prostate cancer, Lymph node recurrence, Stereotactic radiotherapy, Robotic stereotactic radiotherapy
To access this article, please choose from the options below
PII: S0167-8140(09)00149-2
doi:10.1016/j.radonc.2009.04.001
© 2009 Elsevier Ireland Ltd. All rights reserved.
